Substituted quinoxalines as PDE-10 inhibitors
US10562916B2 · kind B2 · utility
3Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2017 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Oct 19, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are cyclic nucleotide phosphodiesterase inhibitors, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.